XML 45 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Merger and Financing (Details)
shares in Millions, $ in Millions
Oct. 31, 2019
USD ($)
Oct. 04, 2019
USD ($)
series
shares
May 08, 2019
USD ($)
Dec. 31, 2019
USD ($)
Jun. 30, 2019
shares
Reverse Merger and Financing          
Number of series of warrants issued | series   3      
Histogenics          
Reverse Merger and Financing          
Asset purchase agreement, cash consideration $ 7.0   $ 6.5    
Percentage of increase in purchase price of asset per month (in percentage) 10.00%        
Histogenics | Level 2          
Reverse Merger and Financing          
Quoted price of assets held for sale of NeoCart       $ 7.0  
Financing SPA          
Reverse Merger and Financing          
Shares issued (in shares) | shares   2.2     2.2
Aggregate purchase price   $ 25.0